We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADSK icon
126
Autodesk
ADSK
$57.1B
$12.2M 0.13%
49,429
+410
+0.8% +$92.1K
IVV icon
127
iShares Core S&P 500 ETF
IVV
$900B
$12.1M 0.12%
22,055
+2,591
+13% +$1.36M
CEG icon
128
Constellation Energy
CEG
$100B
$12M 0.12%
60,137
+17,245
+40% +$3.52M
IT icon
129
Gartner
IT
$12.4B
$12M 0.12%
26,662
-139
-0.5% -$61.8K
ITW icon
130
Illinois Tool Works
ITW
$80.2B
$11.7M 0.12%
49,168
-12,223
-20% -$3.02M
EOG icon
131
EOG Resources
EOG
$75.8B
$11.6M 0.12%
92,212
-2,188
-2% -$281K
HCA icon
132
HCA Healthcare
HCA
$90.8B
$11.4M 0.12%
35,330
-52
-0.1% -$16.9K
MSI icon
133
Motorola Solutions
MSI
$80.5B
$11.3M 0.12%
29,334
-6,614
-18% -$2.39M
SO icon
134
Southern Company
SO
$102B
$11.3M 0.12%
145,850
-533
-0.4% -$40.4K
AMP icon
135
Ameriprise Financial
AMP
$49.1B
$11.2M 0.11%
26,246
-977
-4% -$417K
KKR icon
136
KKR & Co
KKR
$98.1B
$11.1M 0.11%
105,896
+36,292
+52% +$3.69M
GWW icon
137
W.W. Grainger
GWW
$62.2B
$11.1M 0.11%
12,255
-608
-5% -$572K
ICE icon
138
Intercontinental Exchange
ICE
$90.5B
$10.8M 0.11%
78,958
-2,077
-3% -$279K
CVS icon
139
CVS Health
CVS
$119B
$10.7M 0.11%
180,583
-7,245
-4% -$453K
TDG icon
140
TransDigm Group
TDG
$65.6B
$10.6M 0.11%
8,323
+262
+3% +$336K
VLO icon
141
Valero Energy
VLO
$99.8B
$10.6M 0.11%
67,807
+2,070
+3% +$334K
AON icon
142
Aon
AON
$74.2B
$10.5M 0.11%
35,782
-6,401
-15% -$1.89M
DUK icon
143
Duke Energy
DUK
$94.2B
$10.4M 0.11%
104,087
-592
-0.6% -$59.2K
CPRT icon
144
Copart
CPRT
$30.3B
$10.3M 0.11%
190,818
-19,441
-9% -$1.06M
MSCI icon
145
MSCI
MSCI
$41.4B
$10.3M 0.11%
21,384
+4,890
+30% +$2.43M
EQIX icon
146
Equinix
EQIX
$106B
$10.2M 0.1%
13,484
-3,892
-22% -$2.95M
TGT icon
147
Target
TGT
$75.4B
$10.2M 0.1%
68,777
-43,260
-39% -$6.81M
DXCM icon
148
DexCom
DXCM
$33.7B
$10.1M 0.1%
89,460
+2,141
+2% +$271K
FTNT icon
149
Fortinet
FTNT
$127B
$9.97M 0.1%
165,492
-11,839
-7% -$736K
HLT icon
150
Hilton Worldwide
HLT
$73.3B
$9.9M 0.1%
45,368
+819
+2% +$168K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.